| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 57.126 | 87.376 | 80.560 | 20.252 | 14.408 | 116.965 | 17.442 | 35.567 | 167.449 | 111.576 |
| Total Income - EUR | 57.852 | 87.382 | 80.567 | 20.252 | 14.408 | 116.965 | 17.882 | 41.574 | 161.574 | 111.632 |
| Total Expenses - EUR | 17.686 | 8.354 | 7.065 | 10.445 | 12.202 | 27.423 | 10.904 | 34.039 | 153.263 | 25.113 |
| Gross Profit/Loss - EUR | 40.166 | 79.029 | 73.501 | 9.807 | 2.206 | 89.541 | 6.978 | 7.534 | 8.311 | 86.519 |
| Net Profit/Loss - EUR | 38.452 | 77.363 | 72.695 | 9.199 | 1.885 | 88.638 | 6.855 | 7.246 | 7.081 | 84.350 |
| Employees | 4 | 2 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 1 |
Check the financial reports for the company - Biodanus General Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 162 | 0 | 0 | 0 | 0 | 0 | 535 | 134 | 0 | 4.523 |
| Current Assets | 126.034 | 100.795 | 116.495 | 10.250 | 26.515 | 98.958 | 34.845 | 35.306 | 43.731 | 108.311 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.982 | 0 | 0 |
| Receivables | 125.645 | 100.432 | 104.969 | 8.522 | 20.378 | 49.261 | 20.263 | 23.279 | 39.747 | 55.815 |
| Cash | 389 | 363 | 11.526 | 1.728 | 6.137 | 49.697 | 14.581 | 6.046 | 3.984 | 52.495 |
| Shareholders Funds | 112.549 | 77.416 | 82.691 | 9.251 | 2.106 | 90.704 | 27.119 | 7.298 | 14.356 | 84.398 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.646 | 23.379 | 33.804 | 999 | 24.410 | 8.254 | 8.260 | 28.143 | 29.375 | 28.436 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Biodanus General Srl